
ZYUS Life Sciences Announces LIFE Offering of a minimum of C$15 Million and maximum of C$16 Million of Units
ZYUS Life Sciences Announces LIFE Offering of a minimum of C$15 Million and maximum of C$16 Million of Units

ZYUS Life Sciences Announces LIFE Offering of a minimum of C$15 Million and maximum of C$16 Million of Units
Profound Surpasses 2025 TULSA-PRO(TM) Installed Base Goal
Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
Bright Minds closes $175-million (U.S.) public offering
Rocket Doctor arranges $3-million private placement
Bright Minds Biosciences Announces Closing of US$175 Million Public Offering
ROCKET DOCTOR AI INC. ANNOUNCES LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENT
Perimeter Medical signs deal with Intermountain Health
Comprehensive Healthcare Systems Inc. Announces Non-Brokered Private Placement and Shares for Debt Settlement
Lobe Sciences ends FY 2025 with cash of $5.85-million
LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform
Rocket Doctor completes acquisition of Alea Health
Eupraxia receives positive tissue data from Resolve
Aurora Spine receives two U.S. patents
Perimeter Medical Imaging AI Enters Systemwide Agreement with Intermountain Health